News
Academy
Publications
Media
Conferences
Columns
Resources
Webcasts
Subscribe

Sandra Wiederkehr, PhD

Articles by Sandra Wiederkehr, PhD

Table 1-1.jpg

Interventional vs. Non-interventional Study Classification in the EU: Considerations on the Impact of Direct-to-Patient Contacts

ByJean Siebenaler, MD,Sandra Wiederkehr, PhD,Xavier Fournie, MD

October 14th 2016

A new clinical trial regulation in Europe aims to bring about harmonization of European Union (EU) clinical trial multi-country applications. This paper poses a consensual review, fine-tuning, and validation of study classification while further clarifications on this law are sought out.

Table 1-1-New-1481319911768.jpg

Considerations on the Impact of Direct-to-Patient Contacts

ByJean Siebenaler, MD,Sandra Wiederkehr, PhD,Xavier Fournie, MD

October 1st 2016

Examining interventional vs. non-interventional clinical study classification in the EU.

Latest Updated Articles

Interventional vs. Non-interventional Study Classification in the EU: Considerations on the Impact of Direct-to-Patient Contacts
Published: October 14th 2016 | Updated:
Considerations on the Impact of Direct-to-Patient Contacts
Published: October 1st 2016 | Updated:

Trending on Applied Clinical Trials Online

Scaling Recruitment Across Therapeutic Areas and Regions

ACT Brief: AI, Caplyta Approval, and FDA Priority Vouchers

Bezuclastinib Plus Sunitinib Achieves Strong PFS Benefit in Phase III PEAK Trial for Imatinib-Resistant GIST

© 2025 MJH Life Sciences^®

All rights reserved.